S'abonner

Pseudomonas aeruginosa elastase LasB modulates CFTR expression and innate immune responses in airway epithelial cells - 04/04/15

Doi : 10.1016/j.rmr.2015.02.019 
V. Saint-Criq 1, 2, , F. Bastaert 1, 2, 4, A. Hatton 3, A. Edelman 3, J.M. Sallenave 1, 2, 4
1 Inserm U1152, Faculté de Médecine, Hôpital Bichât, Paris, France 
2 Inserm U874, Défense Innée et Inflammation, Institut Pasteur, Paris, France 
3 Inserm U1151, INEM, Paris, France 
4 Université Paris-Diderot, Paris, France 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Introduction

Pseudomonas aeruginosa (P.a.) is an opportunistic pathogen that is responsible for nocosomial infections and is the major bacterium found in the cystic fibrosis (CF) lungs. Our group has shown that host endogenous proteases such as neutrophil elastase are able to cleave and inactivate CFTR in the airways [1]. Here we hypothesize that the P.a. virulence factor elastase LasB could modulate CFTR expression and innate immune responses in airway epithelial cells.

Methods

The effect of recombinant LasB and secretomes from P.a. strains (WT and ΔLasB PAO1, referred as WT-SEC and ΔLasB-SEC) on CFTR integrity was evaluated in the alveolar epithelial cell line A549 infected with the adenovirus Ad GFP-WT-CFTR and in the Calu-3 cell line grown on semi-permeable supports. The P.a. elastase and secretomes were used to treat the corrected CF cell line CFBE41o-WT-CFTR for ion transport experiments in Ussing chambers and the NCI-H292 and the polarized Calu-3 cell lines for the measurement of secreted cytokines and that of elafin, an important mucosal anti-microbial molecule.

Results

SDS-PAGE analysis of the secretomes showed that LasB is the main secreted protein by WT PAO1. Recombinant LasB (10nM) and the WT-SEC (10%) but not the ΔLasB-SEC, induced a slight decrease in CFTR expression in our CFTR overexpressing model. The recombinant elastase did not show any effect on the activity of ENaC or CFTR in Ussing chamber experiments. However, WT-SEC (10%) seemed to decrease CFTR activity as reported by the measurement of forskolin/ibmx induced short-circuit current (ΔIsc) and CFTR(Inh-172)-sensitive ΔIsc, when compared to the effect of the ΔLasB-SEC or the LB medium alone. Finally, recombinant LasB, as well as the WT-SEC but not ΔLasB-SEC decreased IL-6 and elafin secretion whereas it had no effect on IL-8 secretion.

Conclusion

Taken together, our results show that LasB, the major type 2 secretion system virulence factor, is able to modulate the expression of CFTR and its activity when used in the P.a. secretome. Moreover, it targets the immune response by regulating the expression of cytokines and anti-microbial peptides and we are currently investigating the molecular mechanisms and signalling pathways underlying these processes.

Le texte complet de cet article est disponible en PDF.

Keywords : Infection, Inflammation


Plan


© 2015  Publié par Elsevier Masson SAS.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 32 - N° 3

P. 310 - mars 2015 Retour au numéro
Article précédent Article précédent
  • Caractérisation de la néogenèse lymphoïde pulmonaire dans la mucoviscidose et les dilatations des bronches
  • M.N. Lothe-Cartier, C. Martin, I. Fajac, P.R. Burgel
| Article suivant Article suivant
  • Alternative macrophage polarization and role during lung epithelium injury and repair in vivo
  • R. Dagher, V. Besnard, M. Maret, S. Kozelko, F. Hamdi, G. Gautier, R. Kolbeck, A. Humbles, M. Pretolani